Cited by 120Diabetes, Cardiovascular Risks, and LipoproteinsNitric Oxide and Endothelin EffectsAdipokines, Inflammation, and Metabolic Diseases

Insulin resistance in the vasculature

Open access
Mather, Kieren J., Steinberg, Helmut O., Baron, Alain D.·2013·Journal of Clinical Investigation

Abstract

Insulin resistance is typically defined as a reduced ability of insulin to induce glucose uptake by target tissues such as fat and skeletal muscle cells. It accompanies several disease states, including obesity, type 2 diabetes, hepatitis C, and polycystic ovary syndrome, and is a primary feature of metabolic syndrome. Outside of its effects on blood glucose levels, insulin resistance is also associated with a 2- to 3-fold increased risk of cardiovascular mortality. In 1996, Alain Baron, Helmut Steinberg, and colleagues demonstrated that insulin resistance is associated with endothelial dysfunction. This seminal observation led to significant advances in our understanding of insulin's action in health and disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci67166

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The higher vascular risk linked to insulin resistance may be mediated by associated hypertension, hyperglycemia, hyperinsulinemia, dyslipidemia, endothelial dysfunction, hypercoagulability, inflammation, and increased platelet reactivity.

    “The presence of insulin resistance increases the risk of vascular disease, possibly because of associated hypertension, hyperglycemia, hyperinsulinemia, dyslipidemia, endothelial dysfunction, hypercoagulability, inflammation, and increased platelet reactivity.7–9”

    From Pioglitazone after Ischemic Stroke or Transient Ischemic Attack (2016) · cites this paper as [7]

    The opening section links insulin resistance to increased cardiovascular mortality and endothelial dysfunction. Figure 1 describes a possible prothrombotic pathway, and the main text associates inflammation with vascular dysfunction. The paper does not support the full proposed list of mediators: it does not identify hypertension, hyperglycemia, hyperinsulinemia, dyslipidemia, or increased platelet reactivity as explanations for the higher vascular risk. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Insulin resistance raises the risk of vascular disease.

    “The presence of insulin resistance increases the risk of vascular disease, possibly because of associated hypertension, hyperglycemia, hyperinsulinemia, dyslipidemia, endothelial dysfunction, hypercoagulability, inflammation, and increased platelet reactivity.7–9”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Lteif A, Vaishnava P, Baron AD, Mather KJ. Endo- thelin limits insulin action in obese/insulin-resis- tant humans. Diabetes. 2007;56(3):728-734.

Cited by

Sorted by citations

Authors
Mather, K. J., Steinberg, H. O., & Baron, A. D.
Affiliations
  • Indiana University School of Medicine (US)
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Venue
Journal of Clinical Investigation
Published
2013-03-01
Volume
123
Issue
3
Pages
1003-1004
ISSN
0021-9738 (ISSN-L)
OpenAlex
W1983942577
Cited by
120
References
10
Citations by year
2026: 1 · 2025: 6 · 2024: 5 · 2023: 7 · 2022: 5 · 2021: 8 · 2020: 10 · 2019: 11 · 2018: 9 · 2017: 10 · 2016: 13 · 2015: 17 · 2014: 10 · 2013: 8
FWCI
12.59
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
insulin resistance, endothelial dysfunction, vascular system, cardiovascular risk, metabolic syndrome, type 2 diabetes, obesity, polycystic ovary syndrome, hepatitis C, insulin signaling
MeSH terms
Blood Pressure, Body Composition, Diabetes Mellitus, Type 2, Endothelium, Vascular, Glucose, Humans, Insulin, Insulin Resistance, Nitroprusside, Obesity, Regional Blood Flow, Vasodilation, Methacholine Chloride, Muscle, Skeletal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review